Showing results (51-60 of 234) with videos related to
Sort By:
Pageof 24
Journal of Cellular and Molecular Medicine|July 12, 2022
MC4R biased signalling and the conformational basis of biological function selectionsZekun Liu, Victor J HrubyJournal of Chemical Information and Modeling|April 15, 2011
Backbone alignment modeling of the structure-activity relationships of opioid ligandsZhijun Wu, Victor J HrubyACS Omega|October 29, 2019
Toward a Universal μ-Agonist Template for Template-Based Alignment Modeling of Opioid LigandsZhijun Wu, Victor J HrubyExpert Opinion on Drug Discovery|July 13, 2017
Novel approaches to the design of bioavailable melanotropinsYang Zhou, Minying CaiJournal of Medicinal Chemistry|April 18, 2018
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin ReceptorsFrancesco Merlino, Yang Zhou, Minying Cai, et al.ACS Medicinal Chemistry Letters|February 21, 2015
Azepinone-Containing Tetrapeptide Analogues of Melanotropin Lead to Selective hMC4R Agonists and hMC5R AntagonistOlivier Van der Poorten, Krisztina Fehér, Koen Buysse, et al.Journal of Medicinal Chemistry|December 20, 2007
Structure-activity relationships of cyclic lactam analogues of alpha-melanocyte-stimulating hormone (alpha-MSH) targeting the human melanocortin-3 receptorAlexander V Mayorov, Minying Cai, Erin S Palmer, et al.Journal of Medicinal Chemistry|July 29, 2015
Systematic Backbone Conformational Constraints on a Cyclic Melanotropin Ligand Leads to Highly Selective Ligands for Multiple Melanocortin ReceptorsMinying Cai, Udaya Kiran Marelli, Jennifer Bao, et al.Expert Opinion on Investigational Drugs|December 17, 2013
Investigational peptide and peptidomimetic μ and δ opioid receptor agonists in the relief of painAswini Kumar Giri, Victor J HrubyExpert Opinion on Therapeutic Targets|April 2, 2003
Expression-driven reverse engineering of targeted imaging and therapeutic agentsRobert J Gillies, Victor J HrubyPageof 24